Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2014
11/18/2014US8889150 Bacterial vaccine components from Staphylococcus aureus and uses thereof
11/18/2014US8889148 Flavivirus host-range mutations and uses thereof
11/18/2014US8889146 Vaccine
11/18/2014US8889142 Chlamydia trachomatis antigens for vaccine and diagnostic use
11/18/2014US8889141 T-cell receptor
11/18/2014US8889140 Compositions and methods for tissue repair
11/18/2014US8889131 NOTCH inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof
11/18/2014US8889121 Bacterium comprising a regulated rfaH nucleic acid
11/18/2014US8889117 Modular nanoparticles for adaptable vaccines
11/18/2014US8889099 Methods and compositions for delivering peptides
11/13/2014US20140336367 Recombinant nel-like (nell) protein production
11/13/2014US20140336366 Bioconjugate vaccines made in prokaryotic cells
11/13/2014US20140336364 Monoclonal antibody against interferon-gamma (ifn-gamma) inducing factor (ifig, il-18)
11/13/2014US20140336357 Microbial nanowires
11/13/2014US20140336356 Peptide agonists of glp-1 activity
11/13/2014US20140336236 Novel alk and ntrk1 fusion molecules and uses thereof
11/13/2014US20140336133 Methods and compositions for treating huntington's disease
11/13/2014US20140336128 Gigaxonin fusion protein and methods for treating giant axonal neuropathy
11/13/2014US20140336126 Optineurin-derived polypeptides, their nucleic acids and uses thereof
11/13/2014US20140336119 Polypeptides targeting glycosylated muc2 proteins, methods of synthesis, their nucleic acids and uses thereof
11/13/2014US20140336118 Polypeptide for the protection against heart ischemia-reperfusion injury
11/13/2014US20140336117 Modified receptor fusion proteins
11/13/2014US20140336116 Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide
11/13/2014US20140336109 Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
11/13/2014US20140336105 Anti-Inflammatory Peptides And Use Thereof
11/13/2014US20140336104 Acth prophylactic treatment of renal disorders
11/13/2014US20140336069 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
11/13/2014US20140335591 Increased production of secreted proteins by recombinant eukaryotic cells
11/13/2014US20140335573 Fusion Proteins Comprising Type-II Cohesin Modules, Multi-Enzyme Complexes Comprising Same and Uses Thereof
11/13/2014US20140335508 Method for detecting an infection by the hepatitis c virus
11/13/2014US20140335507 Assays for influenza virus hemagglutinins
11/13/2014US20140335504 Human adaptation of h5 influenza
11/13/2014US20140335163 Targeted iduronate-2-sulfatase compounds
11/13/2014US20140335155 COMPOSITION FOR IMPROVING SKIN CONDITIONS, CONTAINING EXTRACELLULAR DOMAIN OF HUMAN BONE MORPHOGENETIC PROTEIN RECEPTOR 1a AS ACTIVE INGREDIENT
11/13/2014US20140335126 V1v2 immunogens
11/13/2014US20140335125 Attenuated and adapted strain of pseudomonas for delivering antigens
11/13/2014US20140335121 Fimbriae type of prophyromonas gulae
11/13/2014US20140335120 Dual delivery system for heterologous antigens
11/13/2014US20140335117 Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
11/13/2014US20140335116 Avoiding narcolepsy risk in influenza vaccines
11/13/2014US20140335115 Suppressors of mature t cells
11/13/2014US20140335114 Hyr1 as a target for active and passive immunization against candida
11/13/2014US20140335108 Utility of insulin-like 6 (insl6) for the treatment of autoimmune diseases
11/13/2014US20140335104 Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
11/13/2014US20140335097 Expression vector
11/13/2014US20140335094 Mammalian cytokines; related reagents and methods
11/13/2014US20140335092 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/13/2014US20140335086 Modified heat shock protein-antigenic peptide complex
11/13/2014US20140335085 Fusion protein
11/13/2014US20140335064 Human skin equivalents expressing exogenous polypeptides
11/13/2014US20140335053 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1
11/13/2014US20140335016 Bacteriophage Gene 3 Protein Compositions and Use as Amyloid Binding Agents
11/11/2014US8884126 Corn variety DE811ASR(BC5)
11/11/2014US8884100 Aromatic prenyltransferase from Cannabis
11/11/2014US8884099 Method of plastid transformation in asteraceae, vector for use therein and plants thus obtained
11/11/2014US8883982 Compositions and methods for increasing serum half-life
11/11/2014US8883971 CTLA4 proteins and their uses
11/11/2014US8883969 Method for production of carotenoid-synthesizing microorganism and method for production of carotenoid
11/11/2014US8883966 RAB6KIFL/KIF20A epitope peptide and vaccines containing the same
11/11/2014US8883964 Compositions comprising modified collagen and uses therefor
11/11/2014US8883963 Peptidomimetics with glucagon antagonistic and GLP 1 agonistic activities
11/11/2014US8883962 Zinc-responsive peptides, and methods of use thereof
11/11/2014US8883756 SDF-1 delivery for treating ischemic tissue
11/11/2014US8883753 Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
11/11/2014US8883742 Peptide increasing fusiogenic capacity of a gamete
11/11/2014US8883740 Peptides, compositions, and uses thereof
11/11/2014US8883736 Compositions and methods for treating and diagnosing cancer
11/11/2014US8883735 Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs
11/11/2014US8883732 Therapeutic application of adiponectin in patients with ventricular fibrillation
11/11/2014US8883730 Human lung surfactant protein, SP-D, modulates eosinophil activation and survival and enhances phagocytosis of apoptotic bosinophils
11/11/2014US8883729 Nanolipoprotein particles and related compositions, methods and systems
11/11/2014US8883726 Fibroblast growth factor 21 variants
11/11/2014US8883724 Active antiangiogenic therapy
11/11/2014US8883722 Human insulin containing additional disulfide bonds
11/11/2014US8883720 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
11/11/2014US8883719 Bacteriorhodopsin protein variants and methods of use for long term data storage
11/11/2014US8883716 Method for treating damaged tissue of the CNS
11/11/2014US8883692 Method for cell surface displaying of target proteins using Bacillus anthracis exosporium
11/11/2014US8883483 Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
11/11/2014US8883480 Antiviral peptide against avian influenza virus H9N2
11/11/2014US8883478 Methods of preparing tissues for xenotransplantation using α-galactosidases
11/11/2014US8883458 Process for preparing L-amino acids using improved strains of the Enterobacteriaceae family
11/11/2014US8883456 Processes of producing a fermentation product
11/11/2014US8883449 Single-chain insulin
11/11/2014US8883448 Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes
11/11/2014US8883446 Human long pentraxin 3 expression system and uses thereof
11/11/2014US8883445 Protein glycosylation modification in methylotrophic yeast
11/11/2014US8883432 Coelenterazine analogues and coelenteramide analogues
11/11/2014US8883431 Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis
11/11/2014US8883413 Compstatin analogs with improved activity
11/11/2014US8883173 Synthetic antigenic peptides and lipopeptides derived from Mycobacterium avium subsp. paratuberculosis
11/11/2014US8883171 Computationally optimized broadly reactive antigens for influenza
11/11/2014US8883169 Immunogen platform
11/11/2014US8883168 Modulation of immune responses by the poxviral K4 protein
11/11/2014US8883165 Modified peptide vaccine derived from influenza M2
11/11/2014US8883161 Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant
11/11/2014US8883160 Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
11/11/2014US8883145 Methods of treatment with DLL4 antagonists and an anti-hypertensive agent
11/11/2014US8883142 Fructosyl peptide oxidase
11/11/2014US8883134 Human interleukin-1 receptor antagonist—hybrid Fc fusion protein
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 2916